Comprehensive Test Bank (Versions A, B, C &
D)
1,000+ Original NGN-Style Questions with Verified Answers and
Detailed Rationales — All Body Systems & Content Areas Covered
Exam: ATI RN Adult Medical-Surgical Proctored Assessment
Versions Included: A, B, C & D (combined content coverage)
Edition: Updated
Format: Next Generation NCLEX (NGN) aligned — Multiple Choice, Matrix,
Case Studies, Prioritization, Delegation
Total Questions: 1,000+ (continuous numbering Q1–Q1000+)
How to Use This Test Bank
This comprehensive test bank covers all content areas tested on the ATI RN
Adult Medical-Surgical Proctored Exam, including content from Versions A, B,
C, and D. Questions are organized by body system and content domain, with
continuous numbering from Q1 to Q1000+. Each question is followed
immediately by the correct answer and a detailed rationale explaining the
clinical reasoning.
Content Areas Covered (Aligned with ATI Blueprint):
Content Area Weight Question Range
Cardiovascular Disorders 15–20% Q1–Q150
,Content Area Weight Question Range
Respiratory Disorders 10–15% Q151–Q280
Gastrointestinal Disorders 10–15% Q281–Q420
Renal & Urinary Disorders 10–15% Q421–Q540
Endocrine & Metabolic Disorders 10–15% Q541–Q660
Neurological Disorders 10–15% Q661–Q780
Musculoskeletal & Integumentary Disorders 5–10% Q781–Q880
Hematologic & Immunologic Disorders 5–10% Q881–Q950
Fluid, Electrolyte & Acid-Base Imbalances 5–10% Q951–Q1000
Perioperative Care & Emergency Response 5–10% Q1001–Q1050+
SECTION 1: CARDIOVASCULAR DISORDERS
(Q1–Q150)
Q1. A nurse is caring for a client with acute myocardial infarction who
reports chest pain rated 8/10. Which action should the nurse take FIRST?
A) Document the pain in the client's medical record
B) Administer prescribed nitroglycerin and reassess
C) Notify the client's family members
D) Offer the client a light snack
,Answer: B
Rationale: Chest pain in acute myocardial infarction indicates ongoing
myocardial ischemia and is life-threatening. Administering prescribed
nitroglycerin addresses the ischemia by dilating coronary arteries and
reducing preload. Documentation (A) is important but does not treat the
patient. Food intake (D) is irrelevant and potentially harmful during acute MI.
Family notification (C) is secondary to immediate patient stabilization.
Q2. A client with heart failure has an ejection fraction of 25% and reports
waking up breathless at night, requiring three pillows to sleep comfortably.
The nurse recognizes that adding which medication would most effectively
reduce hospitalization risk?
A) Amlodipine
B) Digoxin
C) Sacubitril-valsartan
D) Hydralazine alone
Answer: C
Rationale: Sacubitril-valsartan is an ARNI (angiotensin receptor-neprilysin
inhibitor) that reduces mortality and heart failure hospitalizations in patients
with reduced ejection fraction. Amlodipine (A) does not improve outcomes in
HFrEF. Digoxin (B) reduces hospitalizations but does not improve survival.
Hydralazine alone (D) is not as effective as the combination with isosorbide
dinitrate in certain populations.
, Q3. A client with new-onset atrial fibrillation has a ventricular rate of
156/min and is hemodynamically stable with blood pressure 128/78 mm Hg.
The client reports lightheadedness and palpitations. Which intervention
should the nurse anticipate?
A) Immediate synchronized cardioversion
B) Administration of intravenous amiodarone
C) Administration of atropine
D) Initiation of CPR
Answer: B
Rationale: For hemodynamically stable atrial fibrillation with rapid
ventricular response, rate control and rhythm control medications such as IV
amiodarone are appropriate. Synchronized cardioversion (A) is indicated for
hemodynamically unstable patients. Atropine (C) treats bradycardia, not
atrial fibrillation. CPR (D) is not indicated as the patient has a pulse.
Q4. A nurse is assessing a client who has been receiving heparin therapy.
Which laboratory value should the nurse monitor to evaluate therapeutic
response?
A) PT/INR
B) aPTT
C) Platelet count
D) Hemoglobin
Answer: B
Rationale: aPTT (activated partial thromboplastin time) is used to monitor
heparin therapy. PT/INR (A) monitors warfarin therapy. Platelet count (C) is
monitored for heparin-induced thrombocytopenia, but aPTT is the primary